rs76464258

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_000243.3(MEFV):​c.1503C>T​(p.Arg501Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0068 in 1,614,126 control chromosomes in the GnomAD database, including 300 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0087 ( 30 hom., cov: 33)
Exomes 𝑓: 0.0066 ( 270 hom. )

Consequence

MEFV
NM_000243.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12O:1

Conservation

PhyloP100: -4.40

Publications

13 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-3247100-G-A is Benign according to our data. Variant chr16-3247100-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 36501.
BP7
Synonymous conserved (PhyloP=-4.4 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0936 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEFVNM_000243.3 linkc.1503C>T p.Arg501Arg synonymous_variant Exon 5 of 10 ENST00000219596.6 NP_000234.1
MEFVNM_001198536.2 linkc.870C>T p.Arg290Arg synonymous_variant Exon 4 of 9 NP_001185465.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEFVENST00000219596.6 linkc.1503C>T p.Arg501Arg synonymous_variant Exon 5 of 10 1 NM_000243.3 ENSP00000219596.1

Frequencies

GnomAD3 genomes
AF:
0.00867
AC:
1319
AN:
152166
Hom.:
32
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00437
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0117
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.101
Gnomad SAS
AF:
0.0172
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00341
Gnomad OTH
AF:
0.0143
GnomAD2 exomes
AF:
0.0125
AC:
3139
AN:
251492
AF XY:
0.0127
show subpopulations
Gnomad AFR exome
AF:
0.00369
Gnomad AMR exome
AF:
0.00405
Gnomad ASJ exome
AF:
0.0176
Gnomad EAS exome
AF:
0.104
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00301
Gnomad OTH exome
AF:
0.00993
GnomAD4 exome
AF:
0.00661
AC:
9662
AN:
1461842
Hom.:
270
Cov.:
66
AF XY:
0.00683
AC XY:
4970
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.00352
AC:
118
AN:
33480
American (AMR)
AF:
0.00387
AC:
173
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0179
AC:
468
AN:
26136
East Asian (EAS)
AF:
0.0877
AC:
3481
AN:
39698
South Asian (SAS)
AF:
0.0150
AC:
1296
AN:
86246
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53416
Middle Eastern (MID)
AF:
0.00815
AC:
47
AN:
5768
European-Non Finnish (NFE)
AF:
0.00285
AC:
3172
AN:
1111990
Other (OTH)
AF:
0.0147
AC:
889
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
661
1321
1982
2642
3303
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00865
AC:
1318
AN:
152284
Hom.:
30
Cov.:
33
AF XY:
0.00935
AC XY:
696
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00431
AC:
179
AN:
41570
American (AMR)
AF:
0.0117
AC:
179
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
60
AN:
3470
East Asian (EAS)
AF:
0.101
AC:
522
AN:
5182
South Asian (SAS)
AF:
0.0178
AC:
86
AN:
4820
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00341
AC:
232
AN:
68036
Other (OTH)
AF:
0.0147
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
65
129
194
258
323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00466
Hom.:
3
Bravo
AF:
0.00941
Asia WGS
AF:
0.0610
AC:
212
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00439

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:12Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial Mediterranean fever Uncertain:1Benign:4Other:1
May 23, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2023
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Unité médicale des maladies autoinflammatoires, CHRU Montpellier
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 26, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32199921) -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Acute febrile neutrophilic dermatosis Benign:1
Feb 08, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 07, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Autoinflammatory syndrome Benign:1
Mar 12, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial Mediterranean fever, autosomal dominant Benign:1
Feb 08, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.53
DANN
Benign
0.43
PhyloP100
-4.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76464258; hg19: chr16-3297100; COSMIC: COSV54823871; API